Please enable JavaScript or talk to your local administrator to get JavaScript enabled.


Intravesical interaction of Salmonella enterica Typhimurium and p -MAPA in bladder cancer non muscle invasive (CBNMI )

Funder: São Paulo Research Foundation

Funding period
Funding amount
Due to the high incidence of urinary bladder cancer noninvasive muscle (CBNMI), rises the interest in developing new anti-tumor therapeutic modalities based on the use of live attenuated bacteria and their purified products, highlighting Salmonella enterica typhimurium, which has been assessed due to its excellent safety profile, a large propensity for allocation in tumors and a remarkable ability to synthesize functional cytokines. Another aspect is the study of new therapeutic modalities capable of modulating the immune system through the signaling pathways of toll-like receptors (TLRs). Thus, compounds that are capable of acting as agonists of TLRs represent promising candidates for cancer drugs, in this scenario, the P-MAPA immunomodulator, has great versatility and minimal cytotoxicity revealed by in vivo and in vitro studies, opening new perspective to fight some types of cancers, including CBNMI.The proposal is whether the Salmonella enterica typhimurium can effectively reside in tumors of the urinary bladder in vivo and live with bladder microbiota creating opportunities for direct stimulation of inflammatory responses and changes of energy metabolism in association with P-MAPA immunomodulator offering an option therapy with fewer side effects, better tissue repair and less chance of relapse.
Similar projects All >
Sorted by: Start Date
Project list item
Intravesical delivery of an Fc-enhanced CD40 agonist antibody for the treatment of bladder cancer

Bladder Cancer Advocacy Network to Jeffrey Ravetch, David Knorr

USD 300,000
2020 - 2022
Project list item
CD40 agonism for the treatment of bladder cancer

National Cancer Institute to CHRISTOPHER STUART GARRIS

USD 64,554
2020 - 2023
Project list item
Combatting Bladder Cancer by Inducing Epithelial Turnover

National Cancer Institute to SOMAN N ABRAHAM

USD 372,404
2019 - 2021
Project list item
Clonal evolution and molecular stratification of urothelial carcinoma in situ of the urinary bladder

German Research Foundation to Stefan Garczyk, Nadine Gaisa

2019 -



    1112 Oncology and Carcinogenesis

  • RCDC


  • RCDC

    Emerging Infectious Diseases

  • RCDC

    Urologic Diseases




    5.1 Pharmaceuticals

  • Health Research Areas


  • Broad Research Areas

    Basic Science